Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes

Por Bryce Demoret, Jeff Gregg, David A. Liebner, Gabriel Tinoco, Scott Lenobel, James L. Chen
Publicado em 2019-11-01

Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis

Por Dionisia Quiroga, David A. Liebner, Jennifer S. Philippon, Sarah Hoffman, Yubo Tan, James L. Chen, Scott Lenobel, Paul E. Wakely, Raphael Pollock, Gabriel Tinoco
Publicado em 2020-06-01

Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas

Por Nathan D. Seligson, Joy Tang, Dexter X. Jin, Monica P. Bennett, Julia A. Elvin, Kiley Graim, John L. Hays, Sherri Z. Millis, Wayne O. Miles, James L. Chen
Publicado em 2022-04-01

Metastatic breast cancer patient perceptions of somatic tumor genomic testing

Por Elizabeth J. Adams, Sarah Asad, Raquel Reinbolt, Katharine A. Collier, Mahmoud Abdel-Rasoul, Susan Gillespie, James L. Chen, Mathew A. Cherian, Anne M. Noonan, Sagar Sardesai, Jeffrey VanDeusen, Robert Wesolowski, Nicole Williams, Charles L. Shapiro, Erin R. Macrae, Robert Pilarski, Amanda E. Toland, Leigha Senter, Bhuvaneswari Ramaswamy, Clara N. Lee, Maryam B. Lustberg, Daniel G. Stover
Publicado em 2020-05-01